US Stock MarketDetailed Quotes

ABOS Acumen Pharmaceuticals

Watchlist
  • 1.820
  • +0.030+1.68%
Trading Dec 19 11:37 ET
109.35MMarket Cap-1.32P/E (TTM)

Acumen Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Acumen Pharmaceuticals Q3 2024 Earnings Date

Currency：USDNov 12, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
0
0
0
--
--
--
EPS
-0.37
-0.50
-0.13
Miss Est.
-52.27%
-108.33%
-36.87%
Analyst Rating
Strong Buy

Dec 19, 2024

Acumen Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 12, 20242024/Q30.000 / 0.000--
Aug 13, 20242024/Q20.000 / 0.000--
May 14, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 12, 20242024/Q30.000 / 0.000--
Aug 13, 20242024/Q20.000 / 0.000--
May 14, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Acumen Pharmaceuticals Earnings Reports

  • Acumen Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 12 16:33 ET

  • Acumen Pharmaceuticals | 8-K: Acumen Pharmaceuticals Reports Third Quarter 2024 Financial Results and Business Highlights

    Nov 12 12:18 ET

  • Acumen Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 13 16:47 ET

  • Acumen Pharmaceuticals | 8-K: Acumen Pharmaceuticals Reports Second Quarter 2024 Financial Results and Business Highlights

    Aug 13 07:52 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    +3.16%
    Halozyme Therapeutics
    HALO
    +2.52%
    Teradata Corp
    TDC
    +1.83%
    Cars.com
    CARS
    +1.35%
    Collegium Pharmaceutical
    COLL
    +1.27%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Dec 19, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data